Interact to see
Advertisement
Advertisement
FSPHX vs HGHRX
FSPHX vs HGHRX Comparison
Open Charts FSPHX vs HGHRX
FSPHX vs HGHRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FSPHX vs. HGHRX commentary
Jun 24, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a Buy and HGHRX is a Buy.
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 5.78B vs. HGHRX (739M). FSPHX pays higher dividends than HGHRX: FSPHX (0.45) vs HGHRX (0.00). FSPHX was incepted earlier than HGHRX: FSPHX (45 years) vs HGHRX (20 years). HGHRX (1.66) is less costly to investors than FSPHX (0.62). FSPHX is a more actively managed with annual turnover of: 69.00 vs. HGHRX (49.00). FSPHX (0) and HGHRX (0) have matching initial minimum investment requirements. HGHRX annual gain was more profitable for investors over the last year : 18.71 vs. FSPHX (1.68). HGHRX return over 5 years is better than : -13.52 vs. FSPHX (-23.74).
| FSPHX | HGHRX | FSPHX / HGHRX | |
| Total Expense Ratio | 0.62 | 1.66 | 37% |
| Annual Report Gross Expense Ratio | 0.62 | 1.66 | 37% |
| Fund Existence | 45 years | 20 years | - |
| Gain YTD | -10.542 | -0.710 | 1,484% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 5.78B | 739M | 782% |
| Annual Yield % from dividends | 0.45 | 0.00 | - |
| Returns for 1 year | 1.68 | 18.71 | 9% |
| Returns for 3 years | -9.89 | 7.44 | -133% |
| Returns for 5 years | -23.74 | -13.52 | 176% |
| Returns for 10 years | 38.87 | 20.14 | 193% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement